Cargando…
Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021
Thrombosis with thrombocytopenia (TTS) has been identified as a rare adverse event following COVID-19 vaccination with Vaxzevria. We modelled the benefits and risks of Vaxzevria distribution from May to September 2021 in metropolitan France where other vaccines are available, considering French hosp...
Autores principales: | Tran Kiem, Cécile, Andronico, Alessio, Bosetti, Paolo, Paireau, Juliette, Alter, Lise, Boëlle, Pierre-Yves, Fontanet, Arnaud, Lévy-Bruhl, Daniel, Cauchemez, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326661/ https://www.ncbi.nlm.nih.gov/pubmed/34212840 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.26.2100533 |
Ejemplares similares
-
Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22
por: Bosetti, Paolo, et al.
Publicado: (2022) -
Estimating the burden of SARS-CoV-2 in France
por: Salje, Henrik, et al.
Publicado: (2020) -
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France
por: Bosetti, Paolo, et al.
Publicado: (2021) -
Lockdown impact on COVID-19 epidemics in regions across metropolitan France
por: Cauchemez, Simon, et al.
Publicado: (2020) -
SARS-CoV-2 transmission across age groups in France and implications for control
por: Tran Kiem, Cécile, et al.
Publicado: (2021)